Detecting prostate cancer by the intracellular presence of prostate-specific antigen in macrophages, detected in peripheral blood samples by a flow cytometric technique.

Completed

• Conditions: benign prostate hypertrophia; prostate carcinoma; 10038364

• Registration Number: NL-OMON37430
• Lead Sponsor: Atrium Medisch Centrum

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Last Update Posted: 29 April 2024

Recruitment & Eligibility

• Status: Completed
• Sex: Not specified
• Target Recruitment: 150

Inclusion Criteria

- all men, who visit the department of urology with prostate complaints (in the period april 2012-july 2012)
- by which a needle-biopsy is performed for histopathologic examination
- signed informed consent

Exclusion Criteria

- proven prostate pathology

Study & Design

• Study Type: Observational non invasive
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
<p>Detecting prostate cancer by the intracellular presence of prostate-specific<br /><br>antigen in macrophages, detected in peripheral blood samples by a flow<br /><br>cytometric technique.</p><br>

Secondary Outcome Measures

Name	Time	Method
<p>Not applicable</p><br>